WQ
VRTX icon

Wealth Quarterback’s Vertex Pharmaceuticals VRTX Stock Holding History

Wealth Quarterback’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$18K Hold
99
– – 0.01% 378
2021
Q2 		$20K Buy
+99
New +$20.7K 0.01% 357
2020
Q2 		– Sell
-94
Closed -$22.4K – 771
2020
Q1 		$22.4K Sell
94
-12,189
-99% -$2.8M 0.02% 324
2019
Q4 		$4.45K Buy
+12,283
New +$2.49M ﹤0.01% 651

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wealth Quarterback's VRTX Position: Q3 2021 in Review

Wealth Quarterback held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2021 at 99 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #378.

Wealth Quarterback first reported a position in VRTX in Q4 2019 and has held it in 4 quarters since. The position peaked at $22.4K in Q1 2020. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

  • Wealth Quarterback held 99 shares of Vertex Pharmaceuticals worth $18K as of Q3 2021.
  • Wealth Quarterback left its Vertex Pharmaceuticals share count unchanged in Q3 2021.
  • Vertex Pharmaceuticals made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #378 holding.
  • Wealth Quarterback first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • Wealth Quarterback's Vertex Pharmaceuticals position peaked at $22.4K in Q1 2020.
  • 933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.